Glowide Pharmaceuticals Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 16-07-2024
- Paid Up Capital ₹ 2.94 M
as on 16-07-2024
- Company Age 8 YEARS, 7 MONTHS
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 7.80 M
as on 16-07-2024
- Revenue -33.40%
FY 2020
- Profit -30.16%
FY 2020
- Ebitda -331.52%
FY 2020
- Net Worth 8.95%
FY 2020
- Total Assets 37.87%
FY 2020
About Glowide Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 2.94 M.
The company currently has active open charges totaling ₹7.80 M.
Prashant Hadke and Manish Vinayakrao serve as directors at the Company.
- CIN/LLPIN
U74900MH2016PTC273586
- Company No.
273586
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2016
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Glowide Pharmaceuticals Private Limited offer?
Glowide Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Nasal Drops, Anti Infective Drugs & Medicines, Antiviral Drugs, Ophthalmic Drops, Antibacterial Drugs, Anti Infective Agent, Sexual Wellness Products, Erectile Dysfunction Medicine.
Who are the key members and board of directors at Glowide Pharmaceuticals?
Executive Team (1)
PH
Prashant Hadke
Managing DirectorAppointment Date: 26-Feb-2016
Status: Current
Board Members(1)
Financial Performance and Corporate Structure Insights of Glowide Pharmaceuticals.
Glowide Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 33.4% decrease. The company also saw a substantial fall in profitability, with a 30.16% decrease in profit. The company's net worth moved up by a moderate rise of 8.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glowide Pharmaceuticals?
In 2020, Glowide Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Qualicare Farmulations Private Limited
Active
4 years 3 months Prashant Hadke and Manish Vinayakrao are mutual person
Glowide Packaging Private Limited
Active 5 years 4 months Prashant Hadke and Manish Vinayakrao are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 08 Jul 2020 | ₹1.20 M | Open |
Bank Of India Creation Date: 01 Jul 2020 | ₹0.60 M | Open |
Bank Of India Creation Date: 10 Aug 2017 | ₹6.00 M | Open |
How Many Employees Work at Glowide Pharmaceuticals?
Glowide Pharmaceuticals has a workforce of 5 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Feb 06, 2019, Glowide Pharmaceuticals has raised a total of ₹ 3.64 M, with the most recent deal valued at ₹ 0.9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
